Atlas Trials

Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis

Clinical trial NCT06099626 · UNKNOWN

Trial details

NCT number
NCT06099626
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Autoimmune Liver Disease, COVID-19
Start date
2023-01-01
Primary completion
2024-06-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.